{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:13:44Z","timestamp":1790943224002,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.biopsych.2004.05.012","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T14:23:46Z","timestamp":1092493426000},"page":"248-254","source":"Crossref","is-referenced-by-count":79,"title":["Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain"],"prefix":"10.1016","volume":"56","author":[{"given":"Sandra","family":"Ghelardoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"York A","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley I","family":"Rapoport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bosetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2004.05.012_BIB1","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/BF00965147","article-title":"Alterations in monoamine levels in discrete regions of rat brain after chronic administration of carbamazepine","volume":"19","author":"Baf","year":"1994","journal-title":"Neurochem Res"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00007691-199802000-00010","article-title":"Does carbamazepine have a narrow therapeutic plasma concentration range?","volume":"20","author":"Bialer","year":"1998","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0014-2999(95)00516-1","article-title":"Carbamazepine exerts anti-inflammatory effects in the rat","volume":"294","author":"Bianchi","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.mp.4001111","article-title":"Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain","volume":"7","author":"Bosetti","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB5","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1046\/j.1471-4159.2003.02118.x","article-title":"The expression of brain cyclooxygenase-2 is downregulated in the cytosolic phospholipase A2 knockout mouse","volume":"87","author":"Bosetti","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB6","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1046\/j.1471-4159.2003.01701.x","article-title":"Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain","volume":"85","author":"Bosetti","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB8","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1471-4159.2001.00311.x","article-title":"Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids","volume":"77","author":"Chang","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3940(96)13264-X","article-title":"Lithium decreases turnover of arachidonate in several brain phospholipids","volume":"220","author":"Chang","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB10","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1023\/A:1022415113421","article-title":"Chronic lithium treatment decreases brain phospholipase A2 activity","volume":"23","author":"Chang","year":"1998","journal-title":"Neurochem Res"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB11","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1046\/j.1471-4159.1996.67052079.x","article-title":"Attenuation of cyclic AMP production by carbamazepine","volume":"67","author":"Chen","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0929-7855(95)00012-F","article-title":"Cytosolic phospholipase A2","volume":"12","author":"Clark","year":"1995","journal-title":"J Lipid Mediat Cell Signal"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB13","doi-asserted-by":"crossref","first-page":"18342","DOI":"10.1016\/S0021-9258(19)36966-2","article-title":"Substrate specificities and properties of human phospholipases A2 in a mixed vesicle model","volume":"267","author":"Diez","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB14","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/sj.mp.4001087","article-title":"Antiepileptic drugs and agents that inhibit voltage-gated sodium channels prevent NMDA antagonist neurotoxicity","volume":"7","author":"Farber","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0301-0082(95)00016-O","article-title":"Arachidonic acid as a neurotoxic and neurotrophic substance","volume":"46","author":"Katsuki","year":"1995","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB16","unstructured":"Keck PE Jr (2003): Long-term therapy of bipolar illness. J Fam Pract Mar(suppl):S18\u2013S21"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0006-8993(85)90682-1","article-title":"Modulatory effects of prostaglandin D2, E2 and F2 alpha on the postsynaptic actions of inhibitory and excitatory amino acids in cerebellar Purkinje cell dendrites in vitro","volume":"330","author":"Kimura","year":"1985","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB18","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0306-4522(99)00051-2","article-title":"Localization of cytosolic phospholipase A2 messenger RNA mainly in neurons in the rat brain","volume":"92","author":"Kishimoto","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB19","doi-asserted-by":"crossref","unstructured":"Kudo I, Murakami M (2002): Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat 68\u201369:3\u201358","DOI":"10.1016\/S0090-6980(02)00020-5"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB20","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1046\/j.1528-1157.2001.04501.x","article-title":"Effectiveness of first antiepileptic drug","volume":"42","author":"Kwan","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB21","first-page":"309","article-title":"Alternative therapies for bipolar disorder","volume":"46","author":"Lerer","year":"1985","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB22","first-page":"18","article-title":"Carbamazepine and lithium","volume":"21","author":"Lerer","year":"1985","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0327(00)00361-X","article-title":"Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants","volume":"69","author":"Li","year":"2002","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0262-1746(83)90048-3","article-title":"Elevated levels of prostaglandin E2 and thromboxane B2 in depression","volume":"10","author":"Lieb","year":"1983","journal-title":"Prostaglandins Leukot Med"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-4347(01)00328-0","article-title":"Simultaneous high-performance liquid chromatography determination of carbamazepine and five of its metabolites in plasma of epileptic patients","volume":"762","author":"Mandrioli","year":"2001","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"suppl 2","key":"10.1016\/j.biopsych.2004.05.012_BIB27","first-page":"27","article-title":"Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents","volume":"60","author":"Manji","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0168-0102(00)00127-9","article-title":"Inhibitory effect of carbamazepine on inflammatory mediators produced by stimulated glial cells","volume":"38","author":"Matoth","year":"2000","journal-title":"Neurosci Res"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB29","first-page":"982","article-title":"Effects of chronic treatment with trihexyphenidyl and carbamazepine alone or in combination with haloperidol on substance P content in rat brain","volume":"245","author":"Mitsushio","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0920-1211(00)00129-7","article-title":"Effects of carbamazepine on acetylcholine release and metabolism","volume":"40","author":"Mizuno","year":"2000","journal-title":"Epilepsy Res"},{"issue":"suppl 6","key":"10.1016\/j.biopsych.2004.05.012_BIB31","first-page":"9","article-title":"Treatment of bipolar disorder","volume":"64","author":"Moller","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"suppl 13","key":"10.1016\/j.biopsych.2004.05.012_BIB32","first-page":"19","article-title":"An ever-increasing pharmacopoeia for the management of patients with bipolar disorder","volume":"61","author":"Nemeroff","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0920-1211(98)00025-4","article-title":"Effects of carbamazepine on hippocampal serotonergic system","volume":"31","author":"Okada","year":"1998","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB34","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0955-0674(93)90116-8","article-title":"Arachidonic acid in cell signaling","volume":"5","author":"Piomelli","year":"1993","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB35","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1073\/pnas.88.15.6770","article-title":"Bidirectional control of phospholipase A2 activity by Ca2+\/calmodulin-dependent protein kinase II, cAMP-dependent protein kinase, and casein kinase II","volume":"88","author":"Piomelli","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB36","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000026532","article-title":"A history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th century","volume":"38","author":"Post","year":"1998","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB37","first-page":"10","article-title":"Carbamazepine in bipolar illness","volume":"21","author":"Post","year":"1985","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0076-6879(81)72003-2","article-title":"Extraction of tissue lipids with a solvent of low toxicity","volume":"72","author":"Radin","year":"1981","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0920-1211(00)00176-5","article-title":"Effects of antiepileptic drugs on rat platelet aggregation","volume":"43","author":"Rajtar","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB40","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/archpsyc.59.7.592","article-title":"Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?","volume":"59","author":"Rapoport","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1006\/abio.1994.1079","article-title":"1-Hexadecyl-2-arachidonoylthio-2-deoxy-sn-glycero-3-phosphorylcholine as a substrate for the microtiterplate assay of human cytosolic phospholipase A2","volume":"217","author":"Reynolds","year":"1994","journal-title":"Anal Biochem"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev.biochem.70.1.281","article-title":"Regulation of phosphoinositide-specific phospholipase C","volume":"70","author":"Rhee","year":"2001","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB43","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1097\/00001756-199912160-00030","article-title":"85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain","volume":"10","author":"Rintala","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB44","doi-asserted-by":"crossref","unstructured":"Shimoyama R, Ohkubo T, Sugawara K (2000): Monitoring of carbamazepine and carbamazepine 10,11-epoxide in breast milk and plasma by high-performance liquid chromatography. Ann Clin Biochem 37(Pt 2):210\u2013215","DOI":"10.1258\/0004563001899023"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0006-291X(88)81198-7","article-title":"Carbamazepine inhibits electroconvulsive shock-induced inositol trisphosphate (IP3) accumulation in rat cerebral cortex and hippocampus","volume":"153","author":"Vadnal","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biopsych.2004.05.012_BIB46","doi-asserted-by":"crossref","unstructured":"Weerasinghe GR, Rapoport SI, Bosetti F (2004): The effect of chronic lithium on arachidonic acid release and metabolism in rat brain does not involve secretory phospholipase A2 or lipoxygenase\/cytochrome P450 pathways. Brain Res Bull 63:483\u2013487","DOI":"10.1016\/j.brainresbull.2004.04.005"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000632230400592X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000632230400592X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:59:26Z","timestamp":1624582766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000632230400592X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S000632230400592X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2004.05.012","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}